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Background: Human enteric viruses are major agents of foodborne diseases. Because of the absence of a reliable
cell culture method for most of the enteric viruses involved in outbreaks, real-time reverse transcriptase PCR is now
widely used for the detection of RNA viruses in food samples. However this approach detects viral nucleic acids of
both infectious and non infectious viruses, which limits the impact of conclusions with regard to public health
concern. The aim of the study was to develop a method to discriminate between infectious and non-infectious
particles of hepatitis A virus (HAV) and two strains of rotavirus (RV) following thermal inactivation by using
intercalating dyes combined with RT-qPCR.
Results: Once the binding of propidium monoazide (PMA) or ethidium monoazide (EMA) was shown to be
effective on the viral ssRNA of HAV and dsRNA of two strains of RV (SA11 and Wa), their use in conjunction with
three surfactants (IGEPAL CA-630, Tween 20, Triton X-100) prior to RT-qPCR assays was evaluated to quantify the
infectious particles remaining following heat treatment. The most promising conditions were EMA (20 μM) and
IGEPAL CA-630 (0.5%) for HAV, EMA (20 μM) for RV (WA) and PMA (50 μM) for RV (SA11). The effectiveness of the
pre-treatment RT-qPCR developed for each virus was evaluated with three RT-qPCR assays (A, B, C) during thermal
inactivation kinetics (at 37°C, 68 C, 72°C, 80°C) through comparison with data obtained by RT-qPCR and by
infectious titration in cell culture. At 37°C, the quantity of virus (RV, HAV) remained constant regardless of the
method used. The genomic titers following heat treatment at 68°C to 80°C became similar to the infectious titers
only when a pre-treatment RT-qPCR was used. Moreover, the most effective decrease was obtained by RT-qPCR
assay A or B for HAV and RT-qPCR assay B or C for RV.
Conclusions: We concluded that effectiveness of the pre-treatment RT-qPCR is influenced by the viral target and
by the choice of the RT-qPCR assay. Currently, it would be appropriate to further develop this approach under
specific conditions of inactivation for the identification of infectious viruses in food and environmental samples.
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Food-borne enteric viruses, particularly human noroviruses
(NoV), rotaviruses (RV) and hepatitis A virus (HAV), con-
stitute a serious public health concern, since they are re-
sponsible for the vast majority of cases of non-bacterial
gastroenteritis and infectious hepatitis, which may occa-
sionally be fatal [1,2]. These viruses are able to replicate in* Correspondence: sylvie.perelle@anses.fr
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distribution, and reproduction in any mediumthe human gastro-intestinal tract and are dispersed by
shedding in high concentrations into the stools. The stabil-
ity of these viruses with regard to several physical condi-
tions such as pH and temperature, and their resistance to
different treatment systems, contribute significantly to their
persistence in the environment [3,4]. Transmission of these
viruses occurs by the faecal-oral route, primarily through
direct person-to-person contact, but they are also efficiently
transmitted by ingestion of contaminated drinking water or
contaminated foods such as raw shellfish, fresh fruits and
vegetables [5].d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of sensitive, reliable techniques for the detection of enteric
viruses in food and water samples is helpful. The cell cul-
ture system is the gold standard to examine the infectivity
of the isolated viruses. Currently, detection of the main en-
teric viruses on the basis of their infectivity is complicated
by the absence of a reliable cell culture method and the low
contamination levels of food samples. Thus, molecular
methods have been developed for the rapid detection of
viral contamination of foods [6,7]. In 2004, the European
Committee for Standardisation (CEN) asked a technical ad-
visory group (TAG4) to develop standard methods (qualita-
tive / quantitative) for the detection of norovirus and HAV
in foodstuffs. Standard methods have recently been elabo-
rated for a range of risk foods including bottled water, soft
fruits and vegetables. The CEN/ISO/TS 15216 standard
was published in the first half of 2013 and within a year
these proposed protocols will be validated and then pub-
lished as ISO or CEN standard methods [8]. All these
methods are based on a final detection of the viral genome
using real-time reverse transcriptase PCR (RT-qPCR), used
for its sensitivity, specificity, speed and ability to deliver
quantitative data. However, this approach detects the viral
nucleic acids of both infectious and non-infectious viruses.
Therefore, it is important to develop and evaluate simple
and efficient tools which make it possible to overcome the
limitations of the traditional cell culture and PCR assays
[9]. An approach based on an enzymatic treatment with
RNAse combined with a proteinase K treatment was found
to be successful in some cases in distinguishing between
infectious and non-infectious viruses [10-12]. For bacteria,
a relatively recent approach is the treatment of samples
with the DNA-intercalating dyes ethidium monoazide
(EMA) or propidium monoazide (PMA) [13-17]. EMA and
PMA are closely related DNA intercalating dyes with a
photo-inducible azide group that covalently cross-link to
DNA through visible-light photoactivation. PMA has the
advantage of being more selective than EMA for dead cells
as it is more membrane-impermeant [18]. Recently, prom-
ising PMA / EMA treatments have also been tested for
distinguishing between infectious and non-infectious RNA
viruses [19,20]. A study concluded that PMA-RT-PCR as-
says that include pretreatment of enteroviruses and
noroviruses with PMA prior to RT-PCR enable rapid dif-
ferentiation between infectious and non-infectious enteric
viruses when the virus particles are inactivated by heating
at 72°C or 37°C or by using hypochlorite. However, unlike
poliovirus, PMA treatment did not affect detection of heat-
inactivated Norwalk virus by quantitative RT-PCR [21].
Another study found that EMA did not distinguish be-
tween infectious and non-infectious avian influenza virus
particles [22]. Sánchez et al. [23] showed that PMA treat-
ment previous to RT-qPCR detection is a promising alter-
native for assessing HAV infectivity.The usefulness of EMA or PMA for distinguishing be-
tween infectious and non-infectious RV and HAV was in-
vestigated. Both viruses were chosen for their cultivability
and their differences in genomic organization. RV, the lead-
ing cause of severe dehydrating diarrhea in infants and
young children worldwide, are non-enveloped viruses that
possess a genome with 11 segments of double-stranded
RNA contained in a triple-layered protein capsid and be-
long to the Reoviridae. Hepatitis A virus (HAV) infection is
the leading worldwide cause of acute viral hepatitis. HAV
is a positive single-stranded non-enveloped RNA virus
classified in the Hepatovirus genus of the Picornaviridae
family.
The purpose of this study was to develop a method based
on pre-treatment-RT-qPCR assays in order to discriminate
between infectious and non-infectious viruses (HAV, RV)
following thermal inactivation. To this end, the binding of
EMA and PMA to RV and HAV RNA was investigated.
Then, a pre-treatment based on “PMA or EMA +/− surfac-
tant RT-qPCR” was optimized for each virus. Finally, this
method was applied to establish viral thermal inactivation
kinetics through three RT-qPCR assays.
Results
Standard curves of RT-qPCR assays on viral RNA
Linear regression analyses were performed by plotting the
cycle threshold (Ct) values against the logarithm of the
PFU of HAV or TCID50 (50% tissue culture infectious
dose) of RV (SA11 and Wa) with RT-qPCR assays A, B
and C corresponding to the RNA target. The mean param-
eters of the standard curves were as follows: standard
curves respectively obtained with HAV assays A, B and C
showed efficiencies of 100.00%, 95.93%, and 104.83% and
regression coefficients of 0.999, 0.997, 0.996; standard
curves respectively obtained with RV assays A, B and C
showed efficiencies of 90.93%, 94.03%, and 94.23% and re-
gression coefficients of 0.993, 0.986, 0.976 with Wa; stand-
ard curves respectively obtained with RV assays A, B and C
showed efficiencies of 78.83%, 76.53%, and 85.50% and re-
gression coefficients of 0.989, 0.984, 0.989 with SA11.
Evaluation of dyes-RT-qPCR assays on viral RNA
The first experiments studied the efficiency of PMA and
EMA treatments to bind the viral RNA in order to avoid
its detection (RV, HAV) using RT-qPCR assays A and
the potential inhibitory effects of the dyes on RT-qPCR
amplification (Table 1). Viral RNA was treated with dye
concentrations ranging from 10 to 200 μM without
photoactivation and then subjected to RT-qPCR to de-
termine if residual dyes can be inhibitors for RT-qPCR
(Table 1A). In the lowest PMA concentration (10 μM),
an inhibitory effect on RT-qPCR detection was only
found for RV RNA (Wa and SA11) (respectively a de-
crease of - 0.87 log10 and - 1.47 log10 of detected RNA).
Table 1 Binding of dyes to purified viral RNA
[Dye]
μM
HAV RV (Wa) RV (SA11)
PMA EMA PMA EMA PMA EMA
A
10 −0.09 ± 0.11 −0.12 ± 0.09 −0.87 ± 0.30 −0.52 ± 0.19 −1.47 ± 1.27 −0.41 ± 0.27
20 −1.59 ± 0.74 −0.21 ± 0.27 −1.87 −1.18 ± 0.46 −2.51 ± 0.69 −0.31 ± 0.31
50 < LOD −0.99 ± 0.51 < LOD < LOD < LOD −0.47 ± 0.15
100 < LOD < LOD < LOD < LOD < LOD −0.44 ± 0.47
200 < LOD < LOD < LOD < LOD < LOD −0.30 ± 0.41
B
0 −0.33 ± 0.10 −0.33 ± 0.10 −0.49 ± 0.51 −0.49 ± 0.51 −0.07 ± 0.26 −0.07 ± 0.26
10 −0.55 ± 0.13 −0.41 ± 0.26 −0.39 ± 0.11 −0.16 ± 0.06 −0.51 ± 0.16 −0.32 ± 0.32
20 −0.25 ± 0.27 0.37 ± 0.05 −0.27 ± 0.22 −0.37 ± 0.12 −0.68 ± 0.49 −0.28 ± 0.23
50 0.32 ± 0.26 0.43 ± 0.51 −0.34 ± 0.09 −0.23 ± 0.20 −1.60 −0.32 ± 0.23
100 −0.54 ± 0.01 0.03 ± 0.14 −0.38 ± 0.18 0.35 ± 0.24 < LOD 0.52 ± 0.23
200 −0.36 ± 0.13 0.35 ± 0.24 −0.30 ± 0.20 −0.47 ± 0.35 < LOD −0.34 ± 0.16
C
0 −0.33 ± 0.10 −0.33 ± 0.10 −0.49 ± 0.51 −0.49 ± 0.51 −0.07 ± 0.26 −0.07 ± 0.26
10 −2.65 ± 0.51 −0.96 ± 0.27 −1.27 ± 0.12 −0.59 ± 0.24 −1.41 ± 0.51 −0.79 ± 0.50
20 −2.27 ± 0.46 −1.08 ± 0.48 −1.33 ± 0.13 −0.07 ± 0.50 −1.48 ± 0.55 −0.64 ± 0.66
50 −3.16 ± 0.77 −1.16 ± 0.21 −1.75 ± 0.11 −0.62 ± 0.38 −2.96 ± 1.38 −1.22 ± 0.67
100 −2.47 ± 0.37 −1.56 ± 0.33 −2.20 ± 0.50 −1.01 ± 0.11 −3.58 ± 0.65 −2.06 ± 1.63
200 −2.91 ± 0.63 −1.53 ± 0.17 −2.52 ± 1.13 −0.99 ± 0.41 −3.02 ± 1.10 −0.63 ± 0.55
Quantification by RT-qPCR assays A of 108 copies of the genome of viral RNA after monoazide treatment without photoactivation (A), after monoazide treatment
without photoactivation followed by QIA-quick purification (B), after monoazide treatment with photoactivation followed by QIA-quick purification (C). Mean
values ± SD (n=3).
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was also found for HAV RNA (− 1.59 log10). PMA con-
centrations ranging from 50 μM to 200 μM were able to
totally inhibit the RT-qPCR amplification of viral RNA. In-
hibitory effects of EMA were found from 20 μM on RV
(Wa) (− 1.18 log10), and from 50 μM on HAV (− 0.99
log10). Higher concentrations of EMA totally inhibited
RT-qPCR assays on HAV and RV (Wa) viral RNA. In-
versely, no inhibitory effect of any of the EMA concentra-
tions tested was observed with RV (SA11) RNA. The
efficacy of the purification of excess dye in treated RNA
samples using the QIAquick PCR purification kit was
tested to avoid inhibitory effects on RT-qPCR amplifica-
tion (Table 1B). Purification by QIA-quick showed effect-
ive recovery with a decrease in viral titer ≤ − 0.49 log10
with RNA samples not treated with monoazide. The puri-
fication step was found to be effective in removing residual
dye, except for RV (SA11) RNA samples which were
treated with PMA ranging from 50 to 200 μM.
Lastly, optimal PMA / EMA concentrations were deter-
mined on viral RNA samples after dye treatment including
photoactivation and purification steps. The effects of dye
(concentrations of 10 to 200 μM) were determined by
measuring the decrease in RNA quantification by RT-qPCR (Table 1C). PMA at 50 μM enabled the highest re-
duction of the RT-qPCR signal for HAV RNA (− 3.16
log10) and PMA at 100 and 200 μM respectively enabled
the highest reductions of the RT-qPCR signal for RV
(SA11) (− 3.58 log10) and RV (Wa) (− 2.52 log10). EMA
was still found to be less efficient than PMA treatment for
all the viral RNA tested. These data showed that PMA and
EMA are able to bind to viral RNA upon photoactivation
making the RNA unavailable for amplification by RT-
qPCR, although excess dye concentrations can inhibit
RT-qPCR assays. The effectiveness of PMA and EMA treat-
ments depends on the type of dye, the concentration of the
dye and the viral RNA type, although PMA was found to
be the most effective dye for the three viral RNA tested.
Optimization of pretreatment combining dyes and
surfactants before RT-qPCR assays for the selective
detection of infectious viruses
Determination of optimal PMA / EMA concentrations
Table 2 shows the results of experiments conducted with
viruses (HAV and RV (Wa, SA11)) to optimize a specific
procedure based on dye treatment for selective detection
of the viral RNA from infectious viruses using RT-qPCR
assays A.





PMA (μM) EMA (μM)
5 20 50 75 100 5 20 50 75 100
RT-qPCR HAV Infectious 0.03 ± 0.08 0.02 ± 0.08 −0.03 ± 0.02 −0.08 ± 0.01 −0.02 ± 0.05 −0.10 ± 0.17 −0.04 ± 0.02 −0.07 ± 0.07 −0.05 ± 0.05 −0.09 ± 0.03
Inactived −0.88 ± 0.12 −1.01 ± 0.08 −1.06 ± 0.11 −1.13 ± 0.09 −1.14 ± 0.09 −1.24 ± 0.13 −1.75 ± 0.91 −1.31 ± 0.28 −1.25 ± 0.24 −1.17 ± 0.23
RV (SA11) Infectious −0.28 ± 0.38 −0.32 ± 0.44 −0.30 ± 0.33 −0.68 ± 0.41 −0.51 ± 0.28 −0.70 ± 0.12 −0.70 ± 0.30 −0.71 ± 0.08 −0.75 ± 0.09 −0.72 ± 0.09
Inactived −1.16 ± 0.68 −1.45 ± 0.78 −1.60 ± 0.57 −1.70 ± 0.40 −1.71 ± 0.50 −1.12 ± 0.31 −1.13 ± 0.19 −1.05 ± 0.33 −1.06 ± 0.24 −1.07 ± 0.07
RV (Wa) Infectious 0.05 ± 0.09 −0.38 ± 0.34 −0.63 ± 0.02 −0.62 ± 0.14 −0.52 ± 0.15 −0.19 ± 0.05 −0.50 ± 0.20 −0.96 ± 0.31 −1.12 ± 0.16 −1.15 ± 0.13
Inactived −0.24 ± 0.65 −0.62 ± 0.27 −1.00 ± 0.15 −1.44 ± 0.18 −1.45 ± 0.29 −0.52 ± 0.76 −1.51 ± 0.26 −1.81 ± 0.06 −1.72 ± 0.19 −1.48 ± 0.18
Quantification by RT-qPCR assays A after monoazide treatment of 105TCID50 of RV (SA11), 10
3 TCID50 of RV (Wa) and 6× 10
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EMA to detect infectious viruses, HAV, RV (SA11) and
RV (Wa) viruses were either inactivated thermally or not,
and were subjected to dye concentrations ranged from 5
to 100 μM, photoactivation, RNA extraction and quantifi-
cation by RT-qPCR (Table 2). The presence of PMA or
EMA had no effect on detection of the RNA extracted
from infectious HAV regardless of the concentration
tested. Similarly, quantification of RNA extracted from
PMA-treated infectious RV was not strongly affected by
decreases ranging from - 0.05 log10 to - 0.63 log10 for Wa
and from - 0.28 log10 to - 0.68 log10 for SA11, depending
on the PMA concentrations tested. However, quantifica-
tion of RNA extracted from infectious RV was more
strongly affected by EMA treatment, with a decrease be-
tween - 0.19 log10 and - 1.15 log10 for Wa and between -
0.70 log10 and - 0.75 log10 for SA11, depending on the
EMA concentrations tested.
When thermally inactivated viruses were assayed with
PMA RT-qPCR, maximum decreases were found for HAV
(− 1.06 log10 to −1.14 log10) and for RV (SA11) (− 1.60
log10 to - 1.71 log10) with PMA concentrations ranging
from 50 μM to 100 μM, and for RV (Wa) (− 1.44 log10
and - 1.45 log10) with PMA concentrations of 75 μM and
100 μM. When inactivated viruses were assayed with
EMA RT-qPCR, maximum decreases were found for
HAV (− 1.75 log10) with EMA at 20 μM, for RV (SA11)
(− 1.13 log10) with EMA at 20 μM, and for RV (Wa)
(− 1.81 log10) with EMA at 50 μM.
The data obtained with all the negative controls were
as expected. Treatment by PMA / EMA without
photoactivation or with a single exposure of the viruses
to light before RNA extraction did not significantly
affect the RT-qPCR detection of extracted RNA (data
not shown).
The most effective dye concentration for each virus was
experimentally chosen by taking into account the effect of
the dye concentrations on the inactivated and infectious
viruses. In cases where similar data were observed with
different dye concentrations, the lowest dye concentration
was preferred. Thus, 20 μM of EMA for all viruses, 50 μM
of PMA for HAV and RV (SA11) and 75 μM of PMA for
RV (Wa) were selected as optimal concentrations.
Evaluation of pre-treatments combining dye and surfactant
As a second step, Triton X-100, Tween 20 and IGEPAL
CA-630, three widely used nonionic surfactants, were
tested for their efficacy in improving the effects of PMA /
EMA treatment on viral particles (Table 3).
Beforehand, we attempted to evaluate surfactant tox-
icity towards the infectivity of HAV and rotavirus strains,
which would preclude their use as a discriminatory
treatment. One set of HAV viral samples receiving sur-
factants was compared to untreated HAV viral samplesby titration with cell culture. None of the surfactant
treatments significantly reduced the initial HAV titer
(≤ 0.20 log10), which argues in favor of the use of a dye-
surfactant pre-treatment. It was not possible to measure
the toxicity of surfactants to RV strains (Wa and SA11)
because all surfactant doses affected the MA104 cells in
culture (data not shown).
The previously selected optimal dye concentration for
each virus (20 μM of EMA for all viruses, 50 μM of
PMA for HAV and RV (SA11) and 75 μM of PMA for
RV (Wa)) were tested in association with three concen-
trations of three surfactants.
When inactivated HAV was assayed, Tween 20 only
very slightly increased the efficacy of PMA (50 μM)
(<− 0.7 log10) and did not increase the efficacy of EMA
(20 μM) pretreatments. The pretreatments of inactivated
HAV associating PMA (50 μM) with IGEPAL CA-630 or
Triton ×100 improved the processing regardless of the
concentration of surfactant tested. Indeed, the logarith-
mic reductions of RNA detected by RT-qPCR were in-
cluded between - 2.34 log10 and - 2.49 log10 which was
higher than the reduction of 1.06 log10 obtained with
PMA treatment at 50 μM. Similarly, the processing of
inactivated HAV associating EMA (20 μM) with IGEPAL
CA-630 or Triton ×100, regardless of the concentration
of surfactant tested, enhanced the efficacy of the pro-
cessing. Indeed, the logarithmic reductions of RNA
detected by RT-qPCR were included between - 2.23
log10 and - 2.68 log10 which was higher than the reduc-
tion of 1.75 log10 obtained with EMA treatment at
20 μM. Finally, the treatment of HAV by the most
promising IGEPAL CA-630 (0.5%) without monoazide
or photoactivation before RNA extraction did not affect
RT-qPCR detection of extracted RNA, which argues in
favor of the use of a dye-surfactant pre-treatment (data
not shown).
When inactivated RV (SA11) was assayed, the efficacy
of the processing with PMA (50 μM) was always slightly
higher without surfactant. When inactivated RV (SA-11)
was assayed with EMA and surfactants, the highest im-
provement was found with Tween 20 (0.5%) leading to
an increase of reduction of RNA detected by RT-qPCR
of −0.76 log10 compared with treatment with EMA at
20 μM. However, the pre-treatment based on EMA also
seemed to affect RNA detection from infectious RV
(SA11) (− 0.72 log10) more than the pre-treatment based
on PMA (− 0.30 log10). When inactivated RV (Wa) was
assayed, none of the tested surfactants increased the effi-
cacy of the dye pretreatments.
By taking into account all these data, we selected pre-
treatments with EMA (20 μM) and IGEPAL CA-630
(0.5%) for HAV, with EMA (20 μM) for RV (Wa) and
PMA (50 μM) for RV (SA11) for their high efficiencies.
Since different incubation times (30 min, 2 h, overnight)





Dye Triton ×100 Tween 20 IGEPAL CA-630
0.1% 0.5% 1% 0.1% 0.5% 1% 0.1% 0.5% 1%
RT-qPCR
HAV Infectious EMA (20 μM) 0.03 ± 0.07 −0.06 ± 0.06 −0.05 ± 0.05 −0.02 ± 0.09 −0.07 ± 0.09 −0.02 ± 0.06 0.02 ± 0.13 −0.02 ± 0.05 −0.04 ± 0.09
Inactived −2.42 ± 0.04 −2.52 ± 0.10 −2.48 ± 0.01 −1.70 ± 0.05 −1.88 ± 0.29 −1.89 ± 0.08 −2.23 ± 0.41 −2.68 ± 0.01 −2.42 ± 0.07
Infectious PMA (50 μM) −0.07 ± 0.02 −0.07 ± 0.02 0.00 ± 0.02 −0.05 ± 0.06 −0.12 ± 0.07 −0.09 ± 0.09 −0.06 ± 0.08 −0.04 ± 0.05 −0.07 ± 0.10
Inactived −2.34 ± 0.27 −2.49 ± 0.25 −2.51 ± 0.23 −1.74 ± 0.07 −1.70 ±0.09 −1.70 ± 0.11 −2.42 ± 0.27 −2.49 ± 0.34 −2.34 ± 0.19
RV (SA11) Infectious EMA (20 μM) −0.80 ± 0.10 −0.77 ± 0.08 0.47 ± 0.11 0.75 ± 0.14 −0.72 ± 0.07 −0.68 ± 0.09 −0.79 ± 0.07 −0.47 ± 0.09 −0.71 ± 0.09
Inactived −1.66 ± 0.09 1.43 ± 0.15 −1.14 ± 0.28 −1.18 ± 0.17 −1.89 ± 0.77 −1.28 ± 0.20 −1.30 ± 0.13 −1.28 ± 0.30 −0.81 ± 0.27
Infectious PMA (50 μM) −0.74 ± 0.15 −0.77 ± 0.16 −0.91 ± 0.20 0.80 ± 0.11 −0.76 ± 0.20 −0.80 ± 0.20 −0.72 ± 0.14 0.71 ± 0.23 −0.81 ± 0.18
Inactived −1.34 ± 0.18 −1.29 ± 0.13 −1.33 ± 0.22 −1.30 ± 0.15 −1.39 ± 0.16 −1.31 ± 0.49 −1.31 ± 0.27 −1.35 ± 0.25 −1.14 ± 0.39
RV (Wa) Infectious EMA (20 μM) −0.39 ± 0.07 −0.24 ± 0.13 −0.15 ± 0.10 −0.41 ± 0.06 −0.13 ± 0.13 −0.37 ± 0.17 −0.28 ± 0.22 −0.21 ± 0.02 0.36 ± 0.13
Inactived −1.21 ± 0.14 −0.68 ± 0.12 −0.40 ± 0.16 −1.01 ± 0.19 −0.88 ± 0.15 −0.58 ± 0.16 −0.82 ± 0.43 −0.71 ± 0.08 −0.14 ± 0.13
Infectious PMA (75 μM) −0.57 ± 0.14 −0.61 ± 0.18 −0.61 ± 0.13 −0.58 ± 0.15 −0.58 ± 0.11 −0.64 ± 0.14 −0.60 ± 0.16 −0.58 ± 0.15 −0.70 ± 0.16
Inactived −1.23 ± 0.08 −1.11 ± 0.04 −1.20 ± 0.18 −1.21 ± 0.08 −1.15 ± 0.09 −1.15 ± 0.17 −1.21 ± 0.08 −1.15 ± 0.18 −1.23 ± 0.08
Cell culture HAV Infectious None 0.09 ± 0.22 −0.03 ± 0.17 0.02 ± 0.21 0.11 ± 0.11 0.16 ± 0.06 0.04 ± 0.25 0.06 ± 0.17 −0.01 ± 0.01 0.14 ± 0.09
Quantification by RT-qPCR assays A after monoazide treatment combined with surfactants (Triton ×100, Tween-20, IGEPAL CA-630) of 105 TCID50 of RV (SA11), 10
3 TCID50 of RV (Wa) and 6× 10
4 PFU of HAV, infectious
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(data not shown), an incubation time of 2 h was selected
for the following studies.
Kinetic thermal viral inactivation curves and impact of RT-
qPCR assays
The heat sensitivity of HAV and RV (Wa, SA11) at four
temperatures (37°C, 68°C, 72°C, 80°C) was analyzed by
kinetic evaluation of the loss of infectivity in cell culture
compared with the loss of genomic titer in RT-qPCR as-
says with or without pre-treatment. Stable secondary
structures may facilitate the covalent binding of PMA /
EMA to viral RNA rendering the RNA undetectable by
RT-qPCR. Moreover, amplicon length may influence the
effectiveness of these assays. Three RT-qPCR assays
were assayed for each viral target to explore the impact
of the amplified genomic region on the success of the
pre-treatment-RT-qPCR assays in detecting the infec-
tious viruses. The log10 reduction detection limits of the
cell culture technique were −4 log10 PFU of HAV, -5.5
log10 TCID50 of RV (Wa) and −3.5 log10 TCID50 of RV
(SA11). For describing all the inactivation curves, the
log-linear + tail model was found to be the most appro-
priate. Figures 1 and 2 show the values of the parameters
of Equation (2) that characterized the fate of the HAV
and RV strain levels respectively according to the four
different temperatures, and to the three methods of
quantification of the virus titer, i.e. RT-qPCR and pre-
treatment RT-qPCR depending on the three different
RT-qPCR assays used and the infectious titer.
For HAV, the values of Si,0 were not different from zero,
which means that the EMA IGEPAL CA-630 treatment
did not affect virus quantification with regard to the
RT-qPCR method. At 37°C, the level of HAV remained
constant regardless of the method used. For other tempe-
ratures, kmax, which is the inactivation rate, increased with
temperature. Using a Bigelow-type model, relating D-value
to temperature, this increase corresponds to z-values ran-
ging from 17°C to 22°C for EMA-IGEPAL CA-630 -RT-
qPCR and infectious titration methods and of 44°C for the
RT-qPCR method, regardless of the RT-qPCR assay. Con-
fidence intervals of Si,res indicate that the fraction of virus
that can survive thermal treatment differs depending on
the titration method used and the temperature. With
EMA-IGEPAL CA-630 - RT-qPCR and RT-qPCR assay C,
the S2,res value is approximately −1.6 log10, which means
that 1 virus out of 40 is quantifiable after 20 min of treat-
ment regardless of the temperature. With EMA-IGEPAL
CA-630 - RT-qPCR and RT-qPCR assay A or B, between 1
virus out 200 and 1 virus out of 6000 is still quantifiable
after treatment at 68°C and 80°C (with S2,res ranged be-
tween −2.3 log10 and −3.8 log10). For RT-qPCR, S1,res are
much higher than S2,res, but the difference between RT-
qPCR assays A and B and RT-qPCR assay C was alsoobserved for RT-qPCR. For the infectious titration method,
S3,res is around −3.5 log10, close to the values obtained with
EMA-IGEPAL CA-630 - RT-qPCR associated with RT-
qPCR assays A and B.
For RV strains, the values of S2,0 were lower than zero,
which means that the EMA / PMA treatment affected virus
quantification with regard to the RT-qPCR method. Indeed,
the reduction of the concentration of infectious virus due
to the monoazide pre-treatment was about of −0.5 log10 by
using RT-qPCR assay A and is ranged from −1.2 log10
to −2.5 log10 by using RT-qPCR assays B and C. These re-
duction levels were the same for both RV strains. At 37°C,
the level of RV strains remained constant regardless of the
method used. At 68°C, 72°C, and 80°C, the genomic titer of
the RV strains was found to be constant by using the RT-
qPCR method regardless of the RT-qPCR assay tested. The
Si,res confidence intervals indicate that the fraction of virus
that can survive thermal treatment differs depending on
the titration method used.
For the Wa RV strain, with EMA-RT-qPCR and RT-
qPCR assay A, the S2,res value was approximately −1.3
log10 which means 1 virus out of 20 was quantifiable
after 20 min of treatment regardless of the temperature.
With EMA-RT-qPCR and RT-qPCR assays B or C, be-
tween 1 virus out of 104 and 1 virus out of 105, was still
quantifiable after treatment at 68°C, 72°C or 80°C (i.e.
S2,res ranged between −4 log10 and −5 log10). The S3,res
values obtained with the infectious titration method
were similar to the S2,res values of RT-qPCR assays B
and C.
For the SA11 RV strain, with PMA-RT-qPCR and RT-
qPCR assay A, S2,res value is approximately −1.2 log10.
With RT-qPCR assays B and C, S2,res ranged from −2.4
log10 and −3.9 log10. The value of S2,res with these RT-
qPCR assays decreased significantly when the temperature
of treatment increases. S3,res values cannot be estimated as
inactivation after 1 minute of treatment for 68°C, 72°C or
80°C was higher than the LOQ.
For SA11, the kmax value increased with the temperature.
Using a Bigelow-type model, this increase corresponds to
z-values ranging from 15°C to 19°C according to the RT-
qPCR assays for the PMA-RT-qPCR method and of 28°C
for the infectious titration method. For the Wa strain and
EMA-RT-qPCR, the large confidence interval observed for
kmax did not make it possible to detect a temperature effect.
Very fast inactivation of Wa strain, (after 1 minute of treat-
ment, infectious titers were below the limit of detection
(LOD)) only allows to argue that kmax values were higher
than 8.
In conclusion, assays conducted to examine the effi-
ciency of pre-treatment RT-qPCR in minimizing detec-
tion signals from thermally-inactivated viruses were
dependent on virus species, on the temperature of in-
activation and on the RT-qPCR assays.
Figure 1 Thermal inactivation kinetics of HAV. Thermal Inactivation kinetics of HAV (a,b,c), expressed with the log-linear + tail model: log10(Si(t)) =
log10((Si,0− Si,res) ⋅ exp(−kmax ⋅ t) + Si,res) (Equation 2). Plots of the estimated parameters for Equation 2 and the corresponding 95% asymptotic confidence
intervals for HAV. (a) Si,0; (b) kmax; (c) Si,res. The results obtained at 37°C, 68°C, 72°C and 80°C are indicated by▼, ■, ● and ◆ respectively. Symbol shaded
in gray indicates data obtained with cell culture method, symbol in black indicates RT-qPCR and open symbol represents RT-qPCR with pre-treatment.
(- -) Limit of quantification.
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Foodborne viruses have emerged as a major cause of
outbreaks worldwide. Among the factors that affect virus
survival, temperature has a great influence on virus sta-
bility in food as in any other matrix. Therefore, food in-
dustries widely apply temperature as a virus-inactivating
factor. Natural or added constituents of food and the
virus species may influence the rate of virus inactivation
by temperature but higher temperatures provided more
pronounced virus decay [24]. The primary model that
was found to effectively describe thermal virus inactiva-
tion in our study, (i.e. the log-linear + tail primary inacti-
vation model), was similar to the one chosen to describe
thermal inactivation of HAV in raspberries [25]. The in-
fectivity of enteric viruses requires the functional integ-
rity of two major components, the capsid and the
genome [26]. While quantitative RT-PCR is a specific
and sensitive tool for determining the quantities of viral
genomes in the environment and food samples, it does
not discriminate between infectious viruses and non-
infectious viruses that do not pose a threat to health.
Moreover, the virus genome was shown to be more re-
sistant than the infectious virus. So, methods which pro-
vide information about the infectivity are particularly
useful for the detection of enteric viruses and would be
an advantage in a public health perspective [27].
Recently, ethidium monoazide (EMA) and propidium
monoazide (PMA), which are intercalating dyes, have
been used combined with PCR or real-time PCR for the
selective detection of viable microorganisms. In this
study, monoazides were tested in association with sur-
factants in order to develop a technique for determining
the residual infectivity of thermally inactivated enteric
viruses. These assays are based on the penetration of
monoazide, potentially facilitated by the action of surfac-
tants, through damaged or compromised capsids and its
covalent binding to viral RNA, which makes the genome
unavailable for amplification by RT-qPCR.
In this study, it was hypothesized that the PMA /
EMA would be able to enter non-infectious RV / HAV
viruses and easily bind to the dsRNA of RV and to the
highly structured 5’-non coding region (5’-NCR) of HAV
ssRNA targeted by the RT-qPCR assays [28]. The pre-
treatment RT-qPCR assays with the shortest amplifica-
tion fragments for RV (87-bp) and HAV (77-bp) did not
produce data similar to those obtained by measuring the
decrease in the number of infectious particles following
heat treatment. By using both longer amplification frag-
ments (313-bp; 352-bp) targeting two different regions
of RV dsRNA, data obtained with pretreatment RT-
qPCR were very similar suggesting that the targeted re-
gion had not influenced the success of the pretreatment
RT-qPCR for dsRNA. Similarly, both longer amplifica-
tion regions for HAV ssRNA (174-bp; 353-bp) provideddata suggesting that the stable secondary structures may
facilitate covalent binding of monoazide to HAV ssRNA.
Thus, the stable secondary structures may facilitate co-
valent binding of monoazide to viral RNA, rendering the
RNA undetectable by RT-qPCR. Besides the targeted
genome region, this study also showed the influence of
the RT-qPCR assays in terms of length of amplicons for
three viruses. Other studies have shown the influence of
amplification length on the degree of PCR suppression
by monoazide treatment in dead cells [29-31].
The HAV capsid is composed of the structural pro-
teins VP1, VP2, VP3, and possibly VP4, encoded in the
P1 region of the genome [32]. Cell culture-derived rota-
virus preparations contain a mixture of double-layered
particles (DLPs) and triple-layered particles (TLPs). The
innermost layer of the rotavirus particle is made up of
the core protein VP2, the middle layer is composed en-
tirely of VP6, and the outermost layer of RV is com-
posed of two proteins, VP4 and VP7 [33]. VP4 forms
spikes that extend outwards from the surface of the virus
and which have been linked to a variety of functions, in-
cluding initial attachment of the virus to the cell mem-
brane and penetration into the cell by the virion [34].
Indeed, the capsids structures may explain the differ-
ences of efficacy of thermal inactivation and of the pene-
tration of monoazide. The presence of monoazide did
not affect the measurement of HAV, but it slightly af-
fected the measurement of both rotavirus strains. This
effect appeared to be variable (between 0.5 log10 and 2.5
log10) depending on the RT-qPCR assays and therefore
not always an impediment to the use of monoazide pre-
treatment for RV. Nevertheless, this monoazide effect
seems to be dependent on the virus type and should be
evaluated to develop this approach with other viruses.
There is still very little development of monoazide RT-
qPCR methods for determining the infectiosity of enteric
viruses. Among the few studies reported in the literature,
Sánchez et al. [23] found that PMA treatment at 50 μM
was significantly more effective than RNase treatment
for differentiating infectious and thermally-inactivated
HAV (99°C for 5 min), with HAV titers reduced by more
than 2.4 log10. The EMA – IGEPAL CA-630 - RT-qPCR
assay developed in this study was significantly more ef-
fective for differentiating infectious and thermally-
inactivated HAV with HAV titers reduced by more than
3 log10 and 3.8 log10 respectively with the RT-qPCR assays
A and B after 5 min at 80°C. Z values observed in the
present study when infectious titration or pretreatment-
RT-qPCR methods were used are consistent with those
observed in the meta-analysis of inactivation of enteric vi-
ruses in food and water carried out by Bertrand et al. [24].
Nevertheless, when high inactivation temperatures were
applied, clearer discriminations between infectious and
non-infectious viruses were consistently observed with
Figure 2 Thermal inactivation kinetics of RV. Thermal Inactivation kinetics of RV (Wa) (a,b,c) and RV (SA11) (d,e,f) expressed with the log-
linear + tail model: log10(Si(t)) = log10((Si,0 − Si,res) ⋅ exp(−kmax ⋅ t) + Si,res) (Equation 2). Plots of the estimated parameters for Equation 2 and the
corresponding 95% asymptotic confidence intervals for Wa and SA11 respectively. (a, d) Si,0; (b, e) kmax; (c, f) Si,res. The results obtained at 37°C,
68°C, 72°C and 80°C are indicated by ▼, ■, ● and ◆ respectively. Symbol shaded in gray indicates data obtained with cell culture method,
symbol in black by RT-qPCR and open symbol represents RT-qPCR with pre-treatment. (- -) Limit of quantification.
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reported in the present study provide limits that are com-
parable to those determined by others [19,20,22]. As the
pre-enzymatic treatment-PCR approach, monoazide RT-
qPCR depend mainly on capsid integrity as the criterion
for infectivity, and this could be one of the drawbacks of
this technique since virus inactivation may take place by
other means than particle disruption [9].
Optimization of EMA or PMA concentration and the
choice of the RT-qPCR assay, as well as the addition of a
complementary treatment to enhance the penetration of
monoazide into the slightly-damaged capsid may lead to
more effective monoazide treatment. This study showed
that surfactants may be useful to improve monoazide-
RT-qPCR assays for HAV but not for RV.
In conclusion, the lack of information about infectious
risk makes it necessary to evaluate new means of
preventing a positive RT-qPCR signal in the absence of in-
fectious virus. The pre-treatment of enteric viruses with
monoazide alone or in conjunction with other capsid-
disrupting aids prior to RT-qPCR may be optimized to
obtain rapid differentiation between infectious and non-
infectious viruses. This approach can potentially be used
with all non-culturable and difficult to culture viruses but
must be estimated with regard to the specific conditions
of inactivation. Currently, it seems relevant to develop this
approach for the identification of infectious viruses in food
and environmental samples. However the potential mul-
tiple sources of inactivation, such as UVs, storing condi-
tions, temperature, etc., could lead to changes in capsid
protein conformation without compromising capsid integ-
rity [9]. This is why it may be necessary to adapt and
evaluate the dye treatment according to the inactivation
type. Moreover, the efficacy of pre-treatment RT-qPCR as-
says could be affected by the types of samples (various
food and environmental samples) and should be charac-
terized in order to be developed further. Therefore, this
new approach could be very useful for evaluating the sus-
ceptibility of non-culturable enteric viruses (e.g. norovirus,
HAV, HEV) to specific inactivation / disinfection techni-
ques or food processing strategies and could be an alterna-
tive to studies using culturable surrogate viruses that differ
in structure, function and comportment.
Methods
Viruses and cells
HAV strain HM175/18f, clone B (VR-1402) was obtained
from the American Type Culture Collection (ATCC). This
clone replicates rapidly and has cytopathic effects in cell
culture [35]. HAV stock was produced by propagation in
foetal rhesus monkey kidney (FRhK-4) cells (ATCC, CRL-
1688) [36] and titrated by plaque assay [37]. Results were
expressed in plaque-forming units/mL (PFU/mL) and
HAV stock contained 107 PFU/mL.Rotavirus strains SA11 (simian rotavirus A) and Wa (hu-
man rotavirus) were obtained from the Pasteur Institute
(Paris, France) and were propagated in MA-104 rhesus
monkey epithelial cell line (ATCC CRL-2378). MA-104
cells were grown in Minimum Essential Medium -
Glutamax™ (MEM), 1% non-essential amino acids, 10%
foetal bovine serum and 0.5% penicillin-streptomycin (Life
Technologies, France). Cells were incubated at 37°C in an
atmosphere containing 5% CO2 and grown to sub-
confluence. Rotavirus viral stock solutions consisted of an
infected cell culture supernatant. Infected cells were frozen
and thawed once and then clarified using low-speed centri-
fugation (6000 × g) at 4°C to remove residual debris. The
supernatant of SA11 contained 107 TCID50 / mL. The
supernatant containing Wa was then ultracentrifugated at
151,000 ×g for 1 h at 4°C to obtain a higher viral titer. The
pellet was resuspended in PBS to obtain a Wa stock
containing 105 TCID50 / mL. Both virus stocks were di-
vided into aliquots and stored at −80°C. For the infectivity
assay, sub-confluent MA-104 cells seeded in 96-well plates
were washed twice with MEM. Samples were trypsin-
activated for 30 min at 37°C, and then added to MA-104
cells. Plates were incubated 3 days at 37°C. Infectious titers
of RV were expressed as TCID50/mL, according to the
Kärber method.RNA purification of Rotaviruses and HAV
HAV and RV RNA stocks were produced from infected
cell culture supernatants. They were centrifugated at
4,000 g for 30 minutes at 4°C and then the supernatants
were ultracentrifugated at 25,000 g for 25 min at 4°C. Fi-
nally, supernatants were ultracentrifugated at 151,000 g
for 50 min at 4°C and the pellets were suspended in ali-
quots of 0.7 mL of 1× PBS and incubated overnight at 4°C
before virus titration. The viral stocks were then vortexed
for about 10 s before RNA extraction. Volumes of 350 μL
were supplemented with NucliSens® easyMAG™ lysis
buffer (BioMérieux) up to 3 mL and subjected to the
NucliSens® easyMAG™ platform for RNA extraction
by the “off-board Specific A protocol” according to the
manufacturer’s instructions. Lastly, nucleic acids were
eluted in 70 μL of elution buffer and pooled to obtain a
homogenized RNA stock. To avoid contamination of
cellular DNA from the HAV and RV RNA stocks, the
samples were treated with the Turbo DNase free-kit
(Life Technologies) according to the manufacturer’s ins-
tructions. The purified RNA stocks were quantified by
measuring absorbance at 260 / 280 nm with a Nanodrop
ND-100 (Thermoscientific, France) and the free software
available on the “http://endmemo.com/bio/dnacopynum.
php” website. All viral RNA stocks (from HAV, SA11 and
Wa) containing 109 copies / μL were aliquoted and stored
at - 80°C.
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PMA (phenanthridium, 3-amino-8-azido-5-[3-(diethylme-
thylammonio)propyl]-6-phenyl dichloride) was purchased
from VWR (Fontenay sous Bois, France) at 20 mM and di-
luted in ultra pure RNAse-free water to obtain the solutions
used in this study. EMA (phenanthridium, 3-amino-8-azido-
5-ethyl-6-phenyl bromide) (Life Technologies) was dissolved
in absolute ethanol to create the stock concentration of
5 mg / mL and then dissolved in ultra pure RNAse-free
water to obtain the solutions used in this study. The EMA
and PMA solutions were stored at −20°C in the dark. All
the experiments with dyes were performed in light-
transparent 1.5 mL microcentrifuge tubes (VWR).
Binding of dyes to purified viral RNA
The effect of several EMA and PMA treatment pro-
cesses on 108 copies genome of viral RNA (RV, HAV) in
100 μL of phosphate-buffered saline (PBS) 1 ×, pH 7.0,
were evaluated by testing several final dye concentra-
tions (10, 20, 50, 100, 200 μM), with incubation of 2 h at
4°C in the dark and sample exposure to light for 15 min
using the LED-Active® Blue system (IB - Applied Sci-
ence, Barcelona, Spain). To determine whether PMA /
EMA interfere with the ability of RT-qPCR to detect vi-
ruses, controls consisting of viral RNA that was treated
with PMA / EMA without photoactivation were in-
cluded with each dye concentration used. To attempt to
remove the inhibitory effects of residual EMA / PMA
on RT-qPCR, viral RNA treated with each dye concen-
tration without photoactivation was purified using the
QIAquick PCR purification kit (Qiagen, Courtaboeuf,
France) according to the manufacturer’s instructions.
Finally, to determine the efficiency of each concentra-
tion of PMA / EMA tested, treated viral RNA samples
were subjected to photoactivation before the purifica-
tion step using the QIAquick PCR purification kit. The
negative control was a non-treated 1× PBS sample. The
positive control was a non-treated viral RNA sample in
1× PBS. A non-treated viral RNA control sample was
subjected to the photoactivation step to check the effect
of the lamp. Finally, all these samples were subjected to
RNA detection by RT-qPCR assays A. The experiments
were performed three times for all viral RNA.
Determination of the optimal dye concentration for
viruses
The best dye (PMA / EMA) and its optimised concen-
tration were determined for each viral target by testing
five dye concentrations (5 μM, 20 μM, 50 μM, 75 μM,
100 μM). Briefly, in 100 μL of 1× PBS samples of 105
TCID50 of RV (SA11), 10
3 TCID50 of RV (Wa) and 6 ×
104 PFU of HAV were conserved at 4°C or inactivated at
80°C for 10 minutes. Next, samples were incubated with
different dye concentrations for 2 h at 4°C in the darkand then exposed to light for 15 min using the LED-
Active® Blue system. The negative control was an un-
treated 1× PBS sample. The positive controls were the
non-dye-treated viral samples kept at 4°C or inactivated
at 80°C for 10 minutes, used to calculate the reduction
rates of the viral load. To check the effect of the lamp,
the non-dye-treated viral samples kept at 4°C or
inactivated at 80°C for 10 minutes and subjected to the
photoactivation step were used as the controls. To check
the effect of the dyes, the viral samples at 4°C or
inactivated at 80°C for 10 minutes treated with 50 μM of
dye without the photoactivation step were used as the
controls.
Finally, all these samples were subjected to RNA ex-
traction and detection by RT-qPCR assays A. The exper-
iments were performed three times for each virus.Evaluation of the combined effect of dyes and surfactants
Tween 20 and IGEPAL CA-630 were purchased from
Sigma-Aldrich (Saint-Quentin Fallavier, France) and Tri-
ton X-100 from Fisher Bioblock Scientific (Illkirch,
France). These surfactants were dissolved in ultra pure
RNAse-free water to obtain solutions at 1% and 10%. In
100 μL of 1× PBS, samples of 105 TCID50 of RV (SA11),
103 TCID50 of RV (Wa) and 6 × 10
4 PFU of HAV were
stored at 4°C or inactivated at 80°C for 10 minutes. The
HAV and RV (Wa, SA11) samples were further treated
with EMA 20 μM to which different final concentrations
(0.1%, 0.5% and 1%) of the surfactants were added. The
HAV and RV (SA11) samples were treated with PMA
50 μM to which different concentrations (0.1%, 0.5% and
1%) of the surfactants were added. The RV (Wa) samples
were treated with PMA 75 μM to which different con-
centrations (0.1%, 0.5% and 1%) of the surfactants were
added. Next, the samples were incubated for 2 h at 4°C
in the dark and then exposed to light for 15 min using
the LED-Active® Blue system.
The negative control was a non-inactivated and un-
treated 1× PBS sample. For the experiments at 4°C, the
positive control was a non-inactivated and untreated
virus sample incubated for 2 h at 4°C. For the experiments
at 80°C, the positive control was an inactivated (10 min at
80°C) and untreated virus sample incubated for 2 h at 4°C.
All non-inactivated samples and positive controls were
subjected to infectious titration to check the effect of the
surfactants on the infectious viruses. Finally, all these sam-
ples were subjected to RNA extraction and detection by
RT-qPCR assays A. The experiments were performed
three times for each virus. Concentrations of the surfac-
tant (Tween 20, Triton ×100 and IGEPAL CA-630) added
to the treated samples were applied to MA-104 cells in
order to check their cytotoxicity (negative control). The
experiments were performed three times for each virus.
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surfactants
The influence of the incubation time with dyes and sur-
factant were determined for HAV treated with EMA
20 μM+ IGEPAL CA-630 0.5%, SA11 treated with PMA
50 μM and Wa treated with EMA 20 μM. Briefly, sam-
ples of 105 TCID50 of RV (SA11), 10
3 TCID50 of RV
(Wa) and 6 × 104 PFU of HAV were stored in 100 μL of
1× PBS at 4°C or inactivated at 80°C for 10 minutes and
were further incubated with the corresponding selected
dyes and surfactants for 30 min, 2 h and overnight in
the dark and then exposed to light for 15 min using the
LED-Active® Blue system.
The negative control was a non-inactivated and un-
treated 1× PBS sample incubated for 2 h at 4°C. For the
experiments at 4°C, the positive control was a non-
inactivated and untreated virus sample incubated for 2 h
at 4°C. For the experiments at 80°C, the positive control
was an inactivated (10 min at 80°C) and untreated virus
sample incubated for 2 h at 4°C. Additional controls were
performed to check the effect of the IGEPAL CA-630
0.5% alone on HAV regardless of the thermal inactivation
and photoactivation. Finally, all these samples were
subjected to RNA extraction and detection by RT-qPCR
assays A. The experiments were performed three times for
each virus.Thermal inactivation of viruses
Three series of HAV and RV strain (Wa, SA11) samples
were inactivated thermally in 1× PBS by using a water
bath set at 37°C and dry baths at 68°C, 72°C and 80°C.
Aliquots of 50 μL of each virus were incubated for each
temperature for 0, 1, 5, 10 and 20 min. Then, 150 μL of
1× PBS at 4°C were added to the samples and placed on
ice. The negative control was a non-inactivated and un-
treated 1× PBS sample. The positive control was a non-
inactivated and untreated virus sample stored at 4°C.
Three 100 μL series of aliquots corresponding to 105
TCID50 of RV (SA11), 10
3 TCID50 of RV (Wa) and 6 ×
104 PFU of HAV were performed. The first series was
kept to monitor loss of infectivity by performing virus ti-
tration on cells. The second series was subjected to dir-
ect RNA extraction. Finally, the third series was treated
with selected dyes and surfactant. Typically, a final dye
concentration of 20 μM of EMA and IGEPAL CA-630
0.5% were added to HAV aliquots, a final dye concentra-
tion of 20 μM EMA was added to RV (Wa) aliquots, and
a final dye concentration of 50 μM of PMA was added
to RV (SA11) aliquots. Then, all samples were incubated
for 2 h at 4°C in the dark and then exposed to light for
15 min using the LED-Active® Blue system. After photo-
activation, the virus samples were also subjected to nu-
cleic acid extraction. Finally, RNA extracts obtainedfrom the second and third series were quantified by test-
ing the three RT-qPCR assays designed for each viral
target. The experiments were performed three times for
each virus.
Viral RNA extraction
Nucleic acid extraction was performed in untreated virus
samples and samples treated with dyes and surfactants. A
hundred μL of the virus sample were supplemented with
NucliSens® easyMAG™ lysis buffer (BioMérieux) up to
3 mL and subjected to the NucliSens® easyMAG™ platform
for total nucleic acid extraction by the “off-board Specific
A protocol” according to the manufacturer’s instructions.
Lastly, nucleic acids were eluted in 70 μL of elution buffer
and stored at −80°C.
Primers and probes
Three RT-qPCR assays targeting the non-coding region
at the 5’ end (5’-NCR) of HAV which have been de-
scribed by Costafreda et al. [38], and adapted from
Costafreda et al. [38] and Di Pasquale et al. [39,40] were
used. The sequences of the primer pairs and the TaqMan
probes used were as follows:
The HAV RT-qPCR assay A generates amplification
products of 174 bp [38] and was recommended in the
CEN/ISO/TS 15216 (qualitative / quantitative methods) for
detection of HAV in foodstuffs. The sense primer (HAV68)
was 5′-TCACCGCCGTTTGCCTAG-3′, the antisense pri-
mer (HAV241) was 5′-GGAGAGCCCTGGAAGAAAG-3′
and the TaqMan probe (HAV150 -) was 5′-FAM-CCTGA
ACCTGCAGGAATTAA–MGB-3′.
HAV RT-qPCR assay B generates amplification products
of 353 bp. It exhibits the same sense primer and probe as
HAV RT-qPCR model A associated with another antisense
primer named HAV-399R: 5′ -GCCTAAGAGGTTTCACC
CGTAG -3′ designed with Beacon Designer software.
Finally, the HAV RT-qPCR assay C adapted from Di
Pasquale et al. [39,40] generates amplification products of
77 bp. The sense primer (HAVf ISS (459–478)) was 5′-
GCGGCGGATATTGGTGAGTT-3′, the antisense primer
(HAVr ISS (535–515)) was 5′- CAATGCATCCACTGGA
TGAGA-3′ and the TaqMan probe (HAVp ISS (484–
511)) was 5′ ROX- Δ GACAAAAACCATTCAACGCC
GGAGGACT-BHQ2-3′. When comparing to the model
published by Di Pasquale et al. [39,40], “Δ” corresponds to
a deletion of 4 nucleotides and the nucleotides in bold cor-
responds to insertions.
Three RT-qPCR assays targeting the rotaviruses were
used. The RT-qPCR assay which has been described by
Pang et al. [41] in the NSP3 region was used with a
sense primer slightly modified with degenerated bases
for matching with both human and simian strains.
Thus, RV RT-qPCR assay A generates amplification prod-
ucts of 87 bp. The sense primer (Rota NVP3-F) (positions:
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antisense primer (Rota NVP3-R) (positions 1034–1049)
was 5′-GGTCACATAACGCCCC-3′ and the TaqMan
probe (positions 984–1016) was 5′- FAM- ATGAGCACA
ATAGTTAAAAGCTAACACTGTCAA-BHQ1-3′.
RV RT-qPCR assay B generates amplification products
of 313 bp. It exhibits the same antisense primer and
probe as RV RT-qPCR assay A associated with another
sense primer named Rota NSP3-736 F : 5′-GARTGG
TATYTAAGATCWATGGAAT-3′ designed with Beacon
Designer software.
RV RT-qPCR assay C designed in the NSP4 region
with Beacon Designer software generates amplification
products of 352 bp. The sense primer (rotaNSP4_166-
188 F) was: 5′-ATTGCRYTGAAAACRTCAAAATG-3′,
the antisense primer (rotaNSP4_517-493R) was: 5′-GCA
GTCACTTCTYTTGGTTCATAAG-3′ and the TaqMan
probe (rotaNSP4_486-462P) was 5′-ROX-YCCACTTT
CCCAYTCTTCTAGCGTT-BHQ2-3′. Primers and probes
were purchased from Eurofins (Les Ulis, France) and
Applied Biosystems (Courtaboeuf, France).
Real-time RT-qPCR conditions
One-step RT-qPCR amplifications were performed in du-
plicate on a CFX96™ real-time PCR detection system from
Bio-Rad (Marnes-la-Coquette, France). Reactions were
performed in a 25 μL reaction mixture containing 1× of
thermoscript reaction mix, and 0.5 μL of Thermoscript
Plus / Platinum Taq enzyme mix, which are components
of the Platinum® Quantitative RT-PCR ThermoScript™
One-Step System (Fisher Bioblock Scientific, Illkirch,
France), as well as 2 U RNAse inhibitor (Applied
Biosystems), 5 μg of BSA (Ambion), 500 nM of forward
primer, 900 nM of reverse primer, 250 nM of probe and
5 μL of RNA extract. The one-step RT-qPCR program
was as follows: 60 min reverse transcription of RNA at
55°C, followed by a 15 min denaturation step at 95°C, and
finally 45 cycles of 15 s at 95°C, 1 min at 60°C and 1 min
at 65°C. The fluorescence was recorded at the end of the
elongation steps (1 minute at 65°C) by the apparatus for
each amplification cycle. Ct was defined as the PCR cycle
at which the fluorescence intensity exceeded the threshold
value. All samples were characterised by a corresponding
Ct value. Negative samples gave no Ct value. A standard
curve for each system was generated using 10-fold dilution
of purified RNA. The slopes (S) of the regression lines
were used to calculate the amplification efficiency (E) of
the real-time qRT-PCR reactions, according to the for-
mula: E = 10|-1/s| -1 [42].
Data analysis
The viral titers were obtained with cell culture assay and
RT-qPCR according to the pre-treatment. Virus inactiva-
tion was determined by calculating the log10 (Nt/N0),where N0 is the titre of the virus recovered on the posi-
tive control and Nt is the titre of the virus recovered on
the tested sample.
Thermal inactivation kinetics were expressed as the
virus survival ratio
Si tð Þ ¼ Ni tð ÞN0 ð1Þ
where Ni(t) is the virus concentration measured with
method i at time t and N0 is the virus concentration
obtained by the RT-qPCR method.
GInaFiT, a freeware Add-in for Microsoft® Excel devel-
oped by Geeraerd et al. [43] was used to model inactiva-
tion kinetics. GInaFiT makes it possible to choose from
different types of microbial survival models (nine)
according to different statistical criteria (i.e., sum of
squared errors, mean sum of squared errors and its root,
R2, and adjusted R2). According to these criteria, the
“log-linear + tail” inactivation model was found to be the
most appropriate for describing inactivation curves re-
gardless of the virus and the temperature of inactivation.
The log-linear + tail model can be expressed as
followed:
log10 Si tð Þð Þ ¼ log10 Si;0−Si;res
 




−1), Si,res and Si,0 are the model
parameters.
kmax is the first order inactivation constant, i.e. it char-
acterizes the slope of the linear decrease of concentra-
tion expressed as a logarithm. kmax is directly linked to
the D value, the decimal reduction time, kmax = ln(10)/D.
Si,res characterizes the fraction of the population
remaining constant in time, or, otherwise stated, not
undergoing any significant subsequent inactivation re-
gardless of the duration of the inactivation treatment.
Si,0 is the initial survival ratio.
This ratio was expected to be equal to zero if the RT-
qPCR method (i = 1) was used to quantify virus titer. Si,0
can also help to quantify the difference between RT-
qPCR and pretreatment-RTqPCR (i = 2) or the cultural
titration method (i = 3).
GInaFiT also returns the standard error values of the es-
timated parameter. These standard errors were used to
construct asymptotic parameter confidence intervals.
When no inactivation was observed, kmax and Si,res were
presented as zero with no confidence intervals, and the
considered experiments were simply represented with Si,0.
When no quantification was possible after 1 minute of
treatment, corresponding to very fast inactivation, the
limit of quantification (LOQ) value was used to set a value
for kmax and Si,res. kmax was set at its minimum possible
value, ln(10)⋅LOQ and Si,res were set to their maximum
Coudray-Meunier et al. BMC Microbiology 2013, 13:216 Page 15 of 16
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given for either parameter.
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